GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
26 hedge funds and large institutions have $1.88M invested in Grace Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$979K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$62K |
3 |
3
Squarepoint
New York
|
$53K |
4 |
4
Millennium Management
New York
|
$21K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$15K |
Top Sellers
1 |
1
Bank of Montreal
Toronto,
Ontario, Canada
|
$6K |
2 |
2
Morgan Stanley
New York
|
$101K |
3 |
VF
3
Virtu Financial
New York
|
$411K |
4 |
4
Jane Street
New York
|
$0 |
5 |
5
Two Sigma Advisers
New York
|
$0 |